alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › development

development

2 studies tagged development, dated 2022-01-14 to 2024-08-03. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice 2024-08-03
  2. Development of a biosensor for phosphorylated Tau 181 protein detection in Early-Stage Alzheimer's disease 2022-01-14

Studies

2 studies carry this tag.

Date range

2022 to 2024

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Bioelectrochemistry (Amsterdam, Netherlands) 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-08-03 Biomarkers

    Our multimarker blood test interpretation tool is ready for testing in real-world clinical dementia settings.

  2. Development of a biosensor for phosphorylated Tau 181 protein detection in Early-Stage Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Bioelectrochemistry (Amsterdam, Netherlands) 2022-01-14 Biomarkers

    Alzheimer's disease (AD) is the most common form of dementia in the elderly, and there are still no reliable methods for its early detection.

All topic tags with their study counts